Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Alantolactone is a sesquiterpene lactone compound found in the roots of Inula helenium (elecampane). There is some scientific evidence supporting its activity against Staphylococcus aureus, including methicillin-resistant strains (MRSA). Several in vitro studies have demonstrated that alantolactone can inhibit the growth of S. aureus, disrupt biofilm formation, and increase the susceptibility of bacteria to antibiotics. The proposed mechanisms include disruption of bacterial membranes and inhibition of key bacterial enzymes or pathways.

However, the evidence is limited mostly to laboratory and cell culture studies. There are no published clinical trials or robust animal studies demonstrating the efficacy or safety of alantolactone for treating staph infections in humans. While the Inula helenium plant has a history of traditional use for respiratory and digestive ailments, its use specifically for staph infections is based on recent pharmacological research rather than traditional practice.

In summary, alantolactone shows promising antibacterial activity against S. aureus in preclinical studies, but there is insufficient clinical evidence to recommend its use for staph infections in humans at this time. The current scientific support is preliminary and more research, especially in vivo and clinical trials, is needed to determine its efficacy and safety for this purpose.

More about Alantolactone
More about Staph Infections

Other ingredients used for Staph Infections

Other health conditions supported by Alantolactone

Products containing Alantolactone